Glenmark Pharmaceuticals (Glenmark) has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions for cardiovascular disease management, to raise awareness on measuring blood pressure at home from the age of 18.
Glenmark and OMRON Healthcare India's collaboration, named as ‘Take Charge @18’ initiative, comprises of generating effective communication to enhance awareness around the cause via incorporating an inlay card into every OMRON Blood Pressure monitor sold in India. The message conveys the importance of initiating blood pressure screening at the right age which is 18 years.
The objective is to encourage patients and care givers who come across this inlay card to sensitize at least four family members of or above the age of 18 to start monitoring their blood pressure and make it a part of their health regime. This message will also be seamlessly integrated into the OMRON Connect app, ensuring it reaches all its subscribers and also on OMRON social media and websites.
Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1778.80 |
Dr. Reddys Lab | 1207.45 |
Cipla | 1486.00 |
Lupin | 2057.60 |
Zydus Lifesciences | 946.00 |
View more.. |